Advancing Therapeutic Delivery

Granza Bio is a biotechnology company developing a novel delivery "shell" platform to direct therapeutic cargo to specific tissues. Their proprietary delivery vehicles are designed using non-immunogenic proteins equipped with a targeting receptor, achieving targeted tropism to organs of interest. These vehicles offer higher stability than conventional lipid nanoparticles (LNPs) and can encompass a variety of cargo, including proteins, DNA, and RNA. For their lead candidate, Granza Bio is leveraging the discovery of the immune system's powerful suite of weapons, "attack particles". Utilizing their advanced delivery platform, they aim to target these "attack particles" against a range of diseases such as cancer, autoimmune disorders, and infections. Interested to know more? Get in touch info@granzabio.com!

synthetic-biologybiotechhealthcaretherapeuticsoncology

Total Open and Closed Positions

Total open positions, and positions newly closed since the previous update

Department Headcount Over Time

Open positions per department · top 6 at any point in the window

Newly Opened and Closed Positions

Position Churn Rate

Positions closed within 14 days of opening · a high rate suggests posting instability — duplicates, pulled listings, or roles filled through internal or off-market channels

Time-to-Fill Distribution

Days from open to close · closed positions only

Salary Trend Over Time

Monthly median base salary · USD · annualized · p25/p75 dashed

Salary Range by Department

Employment Type

Technical vs. Non-technical

Open positions · by department

Top Roles by Department

Seniority Mix

Derived from job title keywords

Equity Range by Department

Top Skills

Top Tech Stacks

Skills Trend

Change in share of postings · recent 3 months vs. prior 3 months

Tech Stack Evolution

Positions opened per month · top 5 technologies